NTS
Neurotensin/neuromedin N
Also known as: NEUT_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P30990
- Gene
- NTS
- Ensembl
- ENSG00000133636
- Chromosome
- 12
- Canonical length
- 170 aa
- Protein class
- Predicted secreted proteins
- Subcellular location
- Vesicles
- Secretome location
- Secreted to digestive system
OverviewNCBI Gene
This gene encodes a common precursor for two peptides, neuromedin N and neurotensin. Neurotensin is a secreted tridecapeptide, which is widely distributed throughout the central nervous system, and may function as a neurotransmitter or a neuromodulator. It may be involved in dopamine-associated pathophysiological events, in the maintenance of gut structure and function, and in the regulation of fat metabolism. Neurotensin also exhibits antimicrobial activity against bacteria and fungi. Tissue-specific processing may lead to the formation in some tissues of larger forms of neuromedin N and neurotensin. The large forms may represent more stable peptides that are also biologically active. [provided by RefSeq, Oct 2014]
Canonical amino-acid sequenceUniProt
170 residues, UniProt reviewed canonical sequence.
>P30990|NTS
1 MMAGMKIQLV CMLLLAFSSW SLCSDSEEEM KALEADFLTN MHTSKISKAH VPSWKMTLLN
61 VCSLVNNLNS PAEETGEVHE EELVARRKLP TALDGFSLEA MLTIYQLHKI CHSRAFQHWE
121 LIQEDILDTG NDKNGKEEVI KRKIPYILKR QLYENKPRRP YILKRDSYYYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NTS can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.53
- Highest tissue expression
- 156 nTPM
Expression across tissuesHPA
Tissue
- small intestine: 156 nTPM
- hypothalamus: 35 nTPM
- stomach: 35 nTPM
- pituitary gland: 31 nTPM
- hippocampal formation: 15 nTPM
- midbrain: 13 nTPM
Single-cell type
- neuroendocrine cells: 6,928 nCPM
- lymphatic endothelial cells: 590 nCPM
- respiratory secretory cells: 388 nCPM
- respiratory deuterosomal cells: 219 nCPM
- enterocytes: 204 nCPM
- conjunctival goblet cells: 167 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- thalamus: 59 nTPM
- hypothalamus: 44 nTPM
- medulla oblongata: 27 nTPM
- midbrain: 21 nTPM
- cerebral cortex: 20 nTPM
- white matter: 8.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.65
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.23
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- blood vessel diameter maintenance
- negative regulation of gene expression
- neuropeptide signaling pathway
- positive regulation of gene expression
- positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Neurotensin/neuromedin N
- Neurotensin/neuromedin N precursor
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NTS in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NTS as an antibody target. Whether an autoantibody or antibody against NTS could matter depends on whether native NTS is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NTS is annotated as secreted, so native NTS circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label NTS as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...